...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Positives & negatives
16
Sep 15, 2015 09:15AM
3
Sep 15, 2015 10:29AM
1
Sep 15, 2015 10:31AM
1
Sep 15, 2015 11:13AM
7
Sep 15, 2015 12:23PM
4
Sep 16, 2015 12:57PM
6
Sep 16, 2015 01:28PM
3
Sep 16, 2015 01:45PM
8
Sep 16, 2015 02:08PM

SS wrote: "What I don't get is that if this is a blockbuster potentially, why such a low pp? Not many drugs aren't on the radar that go into phase 3 status. So I am perplexed."

Although the Resverlogix website lists that it has "initiated" BETonMACE Phase 3, in almost all correspondence Resverlogix refers to BETonMACE as their "planned" or "proposed" Phase 3 trial. Once enrollment/dosing officially begin and the BETonMACE trial design is disclosed, then we can officially put RVX-208 into the Phase 3 category. Don said last Friday at Rodman and Renshaw that they were just a few short weeks from starting enrollment. There is a potential for a lot to happen in the next month, so hold tight!


3
Sep 16, 2015 03:35PM
10
Sep 16, 2015 03:40PM
9
Sep 16, 2015 04:33PM
5
Sep 17, 2015 10:43AM
Share
New Message
Please login to post a reply